Propensity Score Matching Analysis for Alcohol‐Related Liver Disease by Fangfang Duan, Shanshan Song, Hang Zhai, Yazhi Wang, Jun Cheng, Song Yang

Subjects: “…alcohol‐related liver disease…”
Get full text

Current Views of Torque Teno Virus (TTV) in Liver Diseases by I. V. Maev, T. I. Karlovich, A. I. Burmistrov, I. A. Chekmazov, D. N. Andreev, V. I. Reshetnyak

Get full text

Application of glycyrrhizinic acid in treatment of patients with alcoholic liver disease by I. G. Nikitin, I. Ye. Baykova, V. M. Volynkina, L. M. Gogova, G. I. Storozhakov, M. P. Prushkovskaya

Subjects: “…alcohol-induced liver disease…”
Get full text

Options of dyslipidemia treatment at non-alcoholic fatty liver disease by M. V. Mayevskaya, M. A. Morozova

“…To consider different treatment options for dyslipidemia in non-alcoholic fatty liver disease (NAFLD). Summary. NAFLD occurs in 20-30% of adult population. …”
Get full text

Treatment response rate and life prognosis at autoimmune liver diseases by K. V. Ivashkin, Ye. N. Shirokova, V. T. Ivashkin

“…To carry out comparative analysis of modern studies, to characterize actual modes of treatment and to define prognosis and features of treatment response at various autoimmune liver diseases.Key points. Diagnostics and treatment are the most complex and insufficiently investigated aspects of autoimmune liver diseases. …”
Get full text

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease by Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Stefan Chiriac, Cristina M. Muzica, Catalin Victor Sfarti, Tudor Cuciureanu, Laura Huiban, Carol Stanciu, Anca Trifan

“…Advances in the treatment of chronic viral hepatitis in recent years have opened the way towards reducing mortality in patients with chronic liver disease. This goal has not yet been reached, as the burden of chronic liver disease remains a future major health problem as the incidence of the nonalcoholic fatty liver disease continues to rise. …”
Get full text

Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children by Anna Alisi, Nadia Panera, Carlo Agostoni, Valerio Nobili

“…This study suggested that, in children, adolescents, and adults born SGA, insulin resistance could lead to other metabolic disorders: type 2 diabetes (DM2), dyslipidemia, and nonalcoholic fatty liver disease (NAFLD). NAFLD may evolve to nonalcoholic steatohepatitis (NASH), and it is related to the development of MS. …”
Get full text

Cuproptosis Cell Death Molecular Events and Pathways to Liver Disease by Mao Y, Chen H, Zhu W, Ni S, Luo S, Tang S, Chen Z, Wang Q, Xu J, Tu Q, Chen H, Zhu L

Subjects: Get full text

Complex application of mathematical methods in diagnostics of diffuse liver diseases by I. Yu. Pirogova, S. A. Pyshkin, A. A. Bolotov

“…The standard of diffuse liver disease (DLD) diagnostics, allowing to determine etiology, stage of liver fibrosis (LF), histological activity index (HAI) is the liver biopsy (LB). …”
Get full text

Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management by Artur Kośnik, Maciej Wójcicki

Subjects: Get full text

Validation of the Chronic Liver Disease Questionnaire for MASH (CLDQ-MASH) by Zobair M. Younossi, Maria Stepanova, Issah Younossi, Andrei Racila

Subjects: “…Chronic liver disease…”
Get full text

Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases by Ting Liu, Yu Zhou, Kwang Suk Ko, Heping Yang

“…Most chronic liver diseases (CLDs) are characterized by inflammatory processes with aberrant expressions of various pro- and anti-inflammatory mediators in the liver. …”
Get full text

Clinical Trials in Chronic Liver Disease - What Do They Achieve? by Jenny Heathcote

“…The past 30 years have seen rapid growth in the number of clinical trials in liver disease; due mostly to effective drug discovery programs by the pharmaceutical industry. …”
Get full text

Epidemiologic features of non-alcoholic fatty liver disease in Russia by O. M. Drapkina, V. T. Ivashkin

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake by Kenichiro Yasutake, Motoyuki Kohjima, Manabu Nakashima, Kazuhiro Kotoh, Makoto Nakamuta, Munechika Enjoji

“…The dietary intake of patients with nonalcoholic fatty liver disease (NAFLD) is generally characterized by high levels of carbohydrate, fat, and/or cholesterol, and these dietary patterns influence hepatic lipid metabolism in the patients. …”
Get full text

Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease by Sundeep J. Punamiya, Deepak N. Amarapurkar

Get full text

The role of the pulmonary function laboratory in the management of gastrointestinal and liver diseases by José Alberto Neder, Denis E O’Donnell, Danilo C Berton

Get full text

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease by Elena Buzzetti, Rosa Lombardi, Laura De Luca, Emmanuel A. Tsochatzis

“…Nonalcoholic fatty liver disease (NAFLD) is prevalent in 20–25% of the general population and is associated with metabolic risk factors such as obesity, diabetes mellitus, and dyslipidemia. …”
Get full text

Usefulness of pemafibrate for non-alcoholic fatty liver disease with hypertriglyceridemia by Masahiro Kikuchi, Miho Kikuchi, Masahiro Konishi

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Acute Warfarin Toxicity as Initial Manifestation of Metastatic Liver Disease by Varalaxmi Bhavani Nannaka, Nihar Jani, Masooma Niazi, Dmitry Lvovsky

“…We present a case of acute warfarin toxicity as initial manifestation of metastatic liver disease. Our patient is a 64-year-old woman presenting with epigastric pain and discomfort, found to have unrecordable International Normalized Ratio. …”
Get full text